Transmutex SA, a nuclear engineering company based in Geneva, Switzerland, raised over CHF 20m in the extension of its Series A funding to further develop its pivotal solution to a safer, lower-cost, proliferation-resistant nuclear energy
Tags :Sevan Antreasyan
Spanish pharmaceutical company Ferrer and Swiss clinical stage biotechnology company Asceneuron have announced the signing of a licensing agreement in which Ferrer obtains the exclusive worldwide rights to develop and commercialize ASN90 in progressive supranuclear
The Swiss Federal Supreme Court decided on the dispute about “Commune de Champagne PDO” in two judgements (December 23, 2022, 2C_407/2021; March 22, 2022, 2C_381/2021). The Canton de Vaud had introduced, in January 2021, a PDO “Commune de Champagne” for
Gyrus Capital has acquired healthcare services business Consulcesi Group alongside its founders and management. The company is leading provider of Continuous Medical Education (CME), digital marketing, data analytics and legal services to the healthcare industry.
The European Space Agency (ESA) and the European Broadcasting Union (EBU) have signed an agreement which aims at developing solutions that leverage 5G systems in the context of media delivery technologies. The goal is to
beqom, a company sponsored inter alia by Goldman Sachs and Eurazeo, receives a USD300 million investment by Sumeru Equity Partners and co-investors. Majority of the investment will fuel additional growth in product innovation to better
Forestay Capital, managed by Forestay Capital Management Limited, the closed-end tech fund launched in 2018 by B-FLEXION (previously Waypoint) and the management have sold their equity stake in BlueBotics, a navigation technology company based in St-Sulpice (
Forestay Capital, managed by Forestay Capital Management Limited, the closed-end tech fund launched in 2018 by B-FLEXION (previously Waypoint) and the management have sold their equity stake in BlueBotics, a navigation technology company based in St-Sulpice (
Essential Pharma, a portfolio company of Gyrus Capital, has acquired on December 8, 2021, the worldwide rights – except for the USA and India – to iopidine for the adjunctive treatment of glaucoma, and methergine for treating post-partum hemorrhage
Global investment firm Carlyle has entered into a definitive agreement to acquire AutoForm, the global provider of engineering software for sheet metal forming simulation and Body in White (BiW) assembly simulation, primarily used in the
